New FDA Draft Diversity Action Plan Guide Adds New Measures

By Jessica Karins / June 26, 2024 at 6:28 PM
Updated Story FDA has issued a new draft of its diversity action plans, calling on sponsors to take more steps to diversify trials not only along the lines that are required by the Food and Drug Omnibus Reform Act of 2022 (FDORA) but on metrics like socioeconomic status and geographic location. The guidance is still only in draft form, however, months after FDORA required it to be finalized in December 2023. The new draft guidance , which...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.